Wells Fargo Downgrades Thoratec (THOR) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
St. Jude Medical and Thoratec Announce Definitive Agreement
July 22, 2015 7:00 AM EDTCombination Accelerates Innovation-Based Growth Program and Expands Heart Failure Franchise
St. Jude Medical Will Discuss Transaction on its Second Quarter 2015 Earnings Call Scheduled for 8 a.m. EDT (7 a.m. CDT) on July 22, 2015
ST. PAUL, Minn. & PLEASANTON, Calif.--(BUSINESS WIRE)-- St. Jude Medical (NYSE: STJ) and Thoratec (NASDAQ: THOR) today announced that the Boards of Directors of both companies have unanimously approved a definitive agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec for $63.50 per share in a... More
